"UPMC Hillman Cancer Center - Oakland (Medical Oncology) is a Cancer Treatment Center located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Cancer Center at Magee-Womens Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Cancer Center at Magee-Womens Hospital" #1 sponsor was "Gynecologic Oncology Group" with 8 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Basilea Pharmaceutica" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center at Magee-Womens Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center at Magee-Womens Hospital" are "Ovarian Cancer" (4 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "UPMC Cancer Center at Magee-Womens Hospital" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center at Magee-Womens Hospital" are "Drug" (15 trials), "Radiation" (9 trials), "Procedure" (6 trials), "Biological" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "docetaxel" (3 trials), "LHRH agonist" (2 trials), "adjuvant therapy" (2 trials) and "carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center at Magee-Womens Hospital" are 11 trials for "Female" genders, 7 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Cancer Center at Magee-Womens Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in UPMC Cancer Center at Magee-Womens Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center at Magee-Womens Hospital, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".